Overexpression of RRM2 is related to poor prognosis in oral squamous cell carcinoma
- 8 July 2020
- journal article
- research article
- Published by Wiley in Oral Diseases
- Vol. 27 (2), 204-214
- https://doi.org/10.1111/odi.13540
Abstract
Objectives Ribonucleotide reductase M2 (RRM2) is a rate‐limiting enzyme involved in DNA repair and synthesis. This study aims to investigate the expression level, clinicopathological significance and prognostic value of RRM2 in oral squamous cell carcinoma (OSCC). Materials and methods Human OSCC tissue microarrays were used to detect the expression of RRM2, cancer stem cell (CSCs) markers CD44 and aldehyde dehydrogenase 1 (ALDH1), and the epithelial‐mesenchymal transition (EMT) marker Slug. The correlation of RRM2 expression with clinicopathological parameters was evaluated. The effects of RRM2 on cell proliferation, migration and apoptosis were investigated. Results Compared with normal and dysplastic tissues, the expression of RRM2 in human primary OSCC was significantly increased, and its overexpression was correlated with advanced pathological grade. The overall survival rate of patients with high RRM2 expression was lower than that of patients with low RRM2 expression. The overexpression of RRM2 was significantly associated with OSCC recurrence, and its overexpression was correlated with the CSCs markers CD44 and ALDH1 and the EMT marker Slug. The expression of RRM2 promotes the proliferation and migration of human OSCC cells and inhibits apoptosis. Conclusion RRM2 may be a novel target in the diagnosis, prognosis, and therapy of OSCC.Keywords
This publication has 37 references indexed in Scilit:
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff OptimizationPLOS ONE, 2012
- Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammationOncogene, 2011
- A Novel Molecular Signature Identified by Systems Genetics Approach Predicts Prognosis in Oral Squamous Cell CarcinomaPLOS ONE, 2011
- The role of stem and circulating cells in cancer metastasisJournal of Surgical Oncology, 2011
- Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancerHistopathology, 2010
- MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma linesOral Oncology, 2010
- Stem Cells: It's Good To Have ChoicesThe Journal of the American College of Certified Wound Specialists, 2009
- The new classification of Head and Neck Tumours (WHO) — any changes?Oral Oncology, 2006
- Ribonucleotide ReductasesAnnual Review of Biochemistry, 2006
- Java Treeview—extensible visualization of microarray dataBioinformatics, 2004